Novonesis
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Denmark · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Krogshoejvej 36, Bagsvaerd, Region Hoved...Website
www.novonesis.comRevenue
$4.8 BillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Novonesis
Novonesis, founded in 2024 through the merger of Novozymes and Chr. Hansen, is a global biosolutions company that leverages microbiology, enzymes, and fermentation technologies to help industries improve efficiency, sustainability, and product performance. The company serves sectors including food, agriculture, healthcare, energy, and industrial manufacturing. They focus on developing science-based biological solutions that support healthier lives, more sustainable production processes, and reduced environmental impact across global markets.Explore more
Novonesis Org Chart
Get the full picture
Sign in to uncover key details.
MM
Director, Gbs Corporate Shared Services
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Novonesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Novonesis
Product Launch: Get notified when Novonesis launches new products
Earning: See what the market has to say on Novonesis recently announced quarterly report
Funding: Get notified immidiatlly once Novonesis has new funding data
Click to see if Novonesis had a recent Job posting/layoffs
Check out if Novonesis is spiking on competitors!
Check if Novonesis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Novonesis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Novonesis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Novonesis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novonesis.
Novonesis Tech Stack
A closer look at the technologies used by Novonesis
Most Recent Scoops
Earnings
Novonesis has indicated that H2 organic sales growth will be impacted by three factors, the reversal of a one-time Q1 inventory build-up in the animal segment, partial tariff reimbursements being passed back to customers, and only slight growth expected in the human health segment.
Sales
Earnings
Novonesis has announced an interim dividend of DKK 2.35 per share for H1 of 2026, to be dispersed on 27 August 2026, with 24 August 2026 as the last trading day with dividend.
Earnings
Novonesis has reported organic sales growth of 7% in its Planetary Health Biosolutions division for H1 of the year and 9% in Q2, with an adjusted EBITDA margin of 38.8% in H1 of 2026, up 40 basis points year over year, driven by the Feed Enzyme Alliance acquisition and cost synergies, partially offset by increased commercial resources and currency headwinds.
Earnings, Acquisitions, Finance
Earnings
Novonesis has noted that H2 organic sales growth will be impacted by the reimbursement of US tariffs to customers, representing a minor negative effect included in the full-year outlook, and that the Q1 inventory build-up at a key customer in the animal business will be neutral for the full year, with high comparables expected in Q3.
Sales, Logistics / Supply Chain, Inventory Management, Finance, Tax
Earnings
Earnings, Acquisitions, Business Finance, Finance
Novonesis News & Media
Initiation of Novonesis’ share buyback program
Today, Novonesis will initiate the first tranche (the “First Tranche”) of the EUR 1 billion multi-year share buyback program announced in Company Announcement No. 14, on August 19, 2026. Under the First Tranche, Novonesis will acquire B shares for an aggregate amount of up to EUR 75 million, with the First Tranche expected to end no later than December 17, 2026. Based on the closing share price on September 11, 2026, the First Tranche correspondsNovonesis to build next generation enzyme production facility in India
Novonesis will invest €600 million to expand its site in Patalganga and build a state-of-the-art facility. This marks another step in the company's long-term growth strategy and continued investment in its global production footprint to meet increasing demand.Novonesis (Novozymes) B's Dividend Analysis
Novonesis (Novozymes) B (NVZMY) recently announced a total dividend of $0.37 per share, with the ex-dividend date set for 2026-08-31. This includes a $0.37 per share cash dividend payable on 2026-09-16. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Novonesis
Sign Up For FreeTo access detailed company insights
Novonesis, founded in 2024 through the merger of Novozymes and Chr. Hansen, is a global biosolutions company that leverages microbiology, enzymes, and fermentation technologies to help industries improve efficiency, sustainability, and product performance. The company serves sectors including food, agriculture, healthcare, energy, and industrial ma... Read More
